Millions Are Skipping Their Second Doses of Covid Vaccines
NY Times
APRIL 25, 2021
Nearly 8 percent of those who got initial Pfizer or Moderna shots missed their second doses. State officials want to prevent the numbers from rising.
Sat.Apr 24, 2021 - Fri.Apr 30, 2021
144 
Jolly Good/Teijin Pharma develop VR digital therapeutics for depression
pharmaphorum
APRIL 26, 2021
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.
Join 33,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Calling all pharma marketers
Pharma Times
APRIL 29, 2021
The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.
Introducing the 2020-21 HBA Honorable Mentor and STAR Awardees
Pharma Marketing Network
APRIL 28, 2021
Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. What is the Honorable Mentor Award? The Honorable Mentor award recognizes a man who demonstrates a long-term commitment to advancing women in the workforce, is dedicated to developing, mentoring and promoting women in the industry, and is supportive of the overal
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Proposed amendments to the PM(NOC) Regulations: Patents claiming different salt forms of medicinal ingredients eligible for inclusion on the Patent Register
Pharma in Brief
APRIL 25, 2021
On April 23, 2021, Proposed PM(NOC) Amendments [1] were published in the Canada Gazette, Part I. These amendments permit patents claiming different forms of a medicinal ingredient (e.g., salt forms) to be listed on the patent register and are intended to balance Proposed FDR Amendments [2] published on March 30, 2019 which allow generic manufacturers to file an ANDS for an alternative form of a medicinal ingredient in comparison to the CRP.
Not just COVID-19 vaccines: 5 things that cause blood clots
pharmaphorum
APRIL 30, 2021
Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population. However due to the rarity of incidences from vaccination, myGP explores the most common causes of blood clots and how we can prevent them. Over 11 million doses of COVID-19 vaccines have been given across the UK, with blood clotting observed in a small sample of patients.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
How Europe Sealed a Pfizer Vaccine Deal With Texts and Calls
NY Times
APRIL 28, 2021
The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination campaign. Here’s how it came about.
Study examines solution to gauge adverse drug event risk
Outsourcing Pharma
APRIL 26, 2021
Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.
The role of data science and text mining in the search for new therapies
pharmaphorum
APRIL 28, 2021
Today, most drug discovery programmes begin with the identification and validation of disease modifying biological targets. The primary way to uncover these targets is through searching and reviewing published scientific literature. Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer.
Positive topline results for nirsevimab in RSV
Pharma Times
APRIL 26, 2021
Monoclonal antibody reduced lower respiratory tract infections due to RSV in healthy infants
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Biden to Send Coronavirus Vaccine Abroad
NY Times
APRIL 26, 2021
President Biden will send up to 60 million doses of AstraZeneca’s vaccine to countries pleading for help, but some see a medicine dropper for “a four-alarm fire.”.
ERT, Bioclinica merger unites clinical trial tech teams
Outsourcing Pharma
APRIL 28, 2021
The combination of companies brings together ERTâs clinical endpoint data capabilities and Bioclinicaâs imaging, eClinical and drug-safety solutions.
Cognoa files paediatric autism diagnosis device with FDA
pharmaphorum
APRIL 27, 2021
Cognoa has filed for FDA approval of a digital device that could be used to diagnose autism, which the company argues could redefine care standards. . Autism can be difficult to diagnose as there are no medical markers to show its presence – instead doctors look at the child’s developmental history and behaviour to make a diagnosis. Cognoa hopes to change this with an efficient and accurate approach that could allow diagnosis in primary care that won’t require a lengthy referral to a specialist.
Over a quarter of UK adults have received both COVID-19 vaccine doses
Pharma Times
APRIL 28, 2021
UK government has also offered a first vaccine dose to all individuals in cohorts one to nine
Health Care in the U.S., as Seen From Abroad
NY Times
APRIL 28, 2021
We asked eight people around the world what they thought. It didn’t go well.
Pharma Marketers: Drive Registrations for Your Next Event [INFOGRAPHIC]
Pharma Marketing Network
APRIL 28, 2021
With our growing audience of pharma and healthcare professionals, the Pharma Marketing Network (PMN) leverages its experience in helping drive registrations for top-rated events and conferences that attracts diverse populations at scale. Let’s work together to identify the unique needs of your event and produce maximum engagement. Fill out the form below to learn all the perks of partnering with PMN to make your next event the most successful it can be.
Growing up different and not knowing why: My experience of rare vascular disorder KTS
pharmaphorum
APRIL 27, 2021
Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone. Growing up in Glasgow, Linsey Brady “felt like a freak” and did everything she could to hide what she was told was a vascular deformation on her leg from the rest of the world. She was in her late 20s when, after years of struggling with her mental health and self-medicating with alcohol, she was finally diagnosed with Klippel Trenaunay Syndrome (KTS).
Tagrisso moves closer towards EU approval for early-stage lung cancer
Pharma Times
APRIL 27, 2021
Therapy wins a positive CHMP opinion for the adjuvant treatment of early-stage EGFR-mutated NSCLC
Crohn’s Disease Is on the Rise
NY Times
APRIL 26, 2021
Many think the abdominal disorder starts in childhood, but it can occur at any age and is becoming more prevalent throughout the world.
Thermo Fisher: $17.4b PPD buy ‘natural extension’ for pharma
Outsourcing Pharma
APRIL 26, 2021
The chairman, president and CEO of Thermo Fisher says the acquisition stands to benefit clinical trial and drug development clients in a long list of ways.
Indivior pays $300m to settle Suboxone marketing allegations
pharmaphorum
APRIL 30, 2021
Indivior has paid out $300 million to resolve civil claims from US states after it was last year found guilty against criminal charges of improper marketing of the opioid addiction drug Suboxone. Last year, Indivior reached a $600 million settlement plea deal to settle criminal fraud charges, after US authorities found the company’s conduct had results in improper use of state Medicaid funds.
UK cancer centre to offer breast cancer treatment at home
Pharma Times
APRIL 27, 2021
The Christie NHS Foundation Trust will offer the breast cancer treatment Phesgo to patients in their own homes
New patent expiration for Cumberland Pharms drug VIBATIV
Drug Patent Watch
APRIL 30, 2021
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent expiration for Cumberland Pharms drug VIBATIV appeared first on DrugPatentWatch - Make Better Decisions.
Stronger connections between clinical care, research key to progress: Javara
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
Deep Dive: Market Access
pharmaphorum
APRIL 30, 2021
It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. We take a look at all these intersecting topics in this issue – with experts from across the industry sharing their advice on how companies can navigate thes
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
Pharma Times
APRIL 29, 2021
Nilemdo and Nustendi recommended for around 70,000 eligible adults in England with high cholesterol
How Non-Commercial Pharmacies Accelerate Patients Into Prescription Programs
Drug Channels
APRIL 30, 2021
Today’s guest post comes from Natalie Tyler, Director of Pharmacy Operations & Strategy at ConnectiveRx. Natalie discusses how non-commercial pharmacies boost patient access and adherence to specialty therapies. They also help physicians deliver better care. On May 24 at 1:00 pm ET, ConnectiveRx will host an online panel discussion on non-commercial pharmacy services with experts from ConnectiveRx and AstraZeneca.
PureTech hails new avenue for Alzheimer’s disease treatment
Outsourcing Pharma
APRIL 29, 2021
New preclinical research, published in Nature, suggests a new avenue for Alzheimerâs disease (AD) treatment, through restoring lymphatic flow in the brain.
UK orders 60m ‘booster’ doses of Pfizer/BioNTech COVID vaccine
pharmaphorum
APRIL 29, 2021
The UK has ordered an extra 60 million doses of the Pfizer/BioNTech COVID-19 vaccine, which could be used as a potential booster campaign in the autumn. Health secretary Matt Hancock made the announcement in a press briefing, revealing that officials think they may have to boost protection for the population during the winter. The UK looks on course to lift all coronavirus restrictions by 21st June, following a further easing of regulations in mid-May.
Government injects £37m into genomics and data-driven initiatives
Pharma Times
APRIL 30, 2021
Health Secretary reveals government’s plans for UK life sciences 'transformation'
Quebec Prohibits Financial Assistance by Drug Manufacturer for Patients’ Drug Costs
Pharma in Brief
APRIL 29, 2021
At the end of 2016, the previous Quebec government prohibited a number of common commercial practices by drug manufacturers and pharmacists with the aim of fostering greater price competition between drug manufacturers and reducing the cost of the public drug insurance scheme. [1]. Among the new prohibitions was one that would prohibit a manufacturer from offering any financial assistance to patients to help cover the cost of a drug on the provincial List of Medications (Quebec’s formulary).
Tapping into ePRO yields cost, accuracy benefits: Phastar
Outsourcing Pharma
APRIL 29, 2021
A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.
AZ posts solid Q1 results as Alexion merger looms
pharmaphorum
APRIL 30, 2021
AstraZeneca’s not-for-profit coronavirus vaccine has bit into margins in Q1, although revenues were ahead of expectations as the company heads towards completion of its $39bn acquisition of Alexion. . The company posted Q1 product sales of $7.26bn, ahead of consensus forecasts of around $6.84 billion, with total revenues up 15% compared with last year’s Q1 to $7.3bn.
UK buys another 60 million doses of Pfizer/BioNTech vaccine
Pharma Times
APRIL 30, 2021
Extra doses will be used for UK's planned booster vaccination programme in autumn
New patent for Biogen Idec drug TECFIDERA
Drug Patent Watch
APRIL 29, 2021
Annual Drug Patent Expirations for TECFIDERA Tecfidera is a drug marketed by Biogen Idec Inc and is included in one NDA. It is available from two suppliers. There is one…. The post New patent for Biogen Idec drug TECFIDERA appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content